Global Transdermal Drug Patches Market Growth 2020-2025

Publisher Name :
Date: 11-Sep-2020
No. of pages: 167

According to this study, over the next five years the Transdermal Drug Patches market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transdermal Drug Patches business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Transdermal Drug Patches, covering the supply chain analysis, impact assessment to the Transdermal Drug Patches market size growth rate in several scenarios, and the measures to be undertaken by Transdermal Drug Patches companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Fentanyl Transdermal Patch

- Nicotine Transdermal Patch

- Buprenorphine Transdermal Patch

- Clonidine Transdermal Patch

- Oxybutynin Transdermal Patch

- Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Used for Hypertension

- Used for Contraception

- Used for Analgesia

- Used for Smoking Cessation

- Used for Angina

- Used for Hormone Replacement

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Noven

- DURECT Corporation

- Mylan

- Johnson & Johnson

- Agile Therapeutics

- Novartis

- Hercon Pharmaceuticals

- Teikoku Pharma USA

- Pocono

- Immune Pharmaceuticals

- Xel Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Transdermal Drug Patches consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Transdermal Drug Patches market by identifying its various subsegments.

- Focuses on the key global Transdermal Drug Patches manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Transdermal Drug Patches with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Transdermal Drug Patches submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Transdermal Drug Patches Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Patches Consumption 2015-2025
2.1.2 Transdermal Drug Patches Consumption CAGR by Region
2.2 Transdermal Drug Patches Segment by Type
2.2.1 Fentanyl Transdermal Patch
2.2.2 Nicotine Transdermal Patch
2.2.3 Buprenorphine Transdermal Patch
2.2.4 Clonidine Transdermal Patch
2.2.5 Oxybutynin Transdermal Patch
2.2.6 Others
2.3 Transdermal Drug Patches Consumption by Type
2.3.1 Global Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2015-2020)
2.3.3 Global Transdermal Drug Patches Sale Price by Type (2015-2020)
2.4 Transdermal Drug Patches Segment by Application
2.4.1 Used for Hypertension
2.4.2 Used for Contraception
2.4.3 Used for Analgesia
2.4.4 Used for Smoking Cessation
2.4.5 Used for Angina
2.4.6 Used for Hormone Replacement
2.5 Transdermal Drug Patches Consumption by Application
2.5.1 Global Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
2.5.2 Global Transdermal Drug Patches Value and Market Share by Type (2015-2020)
2.5.3 Global Transdermal Drug Patches Sale Price by Type (2015-2020)

3 Global Transdermal Drug Patches by Company
3.1 Global Transdermal Drug Patches Sales Market Share by Company
3.1.1 Global Transdermal Drug Patches Sales by Company (2018-2020)
3.1.2 Global Transdermal Drug Patches Sales Market Share by Company (2018-2020)
3.2 Global Transdermal Drug Patches Revenue Market Share by Company
3.2.1 Global Transdermal Drug Patches Revenue by Company (2018-2020)
3.2.2 Global Transdermal Drug Patches Revenue Market Share by Company (2018-2020)
3.3 Global Transdermal Drug Patches Sale Price by Company
3.4 Global Transdermal Drug Patches Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Transdermal Drug Patches Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Transdermal Drug Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Transdermal Drug Patches by Regions
4.1 Transdermal Drug Patches by Regions
4.2 Americas Transdermal Drug Patches Consumption Growth
4.3 APAC Transdermal Drug Patches Consumption Growth
4.4 Europe Transdermal Drug Patches Consumption Growth
4.5 Middle East & Africa Transdermal Drug Patches Consumption Growth

5 Americas
5.1 Americas Transdermal Drug Patches Consumption by Countries
5.1.1 Americas Transdermal Drug Patches Consumption by Countries (2015-2020)
5.1.2 Americas Transdermal Drug Patches Value by Countries (2015-2020)
5.2 Americas Transdermal Drug Patches Consumption by Type
5.3 Americas Transdermal Drug Patches Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Transdermal Drug Patches Consumption by Regions
6.1.1 APAC Transdermal Drug Patches Consumption by Regions (2015-2020)
6.1.2 APAC Transdermal Drug Patches Value by Regions (2015-2020)
6.2 APAC Transdermal Drug Patches Consumption by Type
6.3 APAC Transdermal Drug Patches Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Transdermal Drug Patches by Countries
7.1.1 Europe Transdermal Drug Patches Consumption by Countries (2015-2020)
7.1.2 Europe Transdermal Drug Patches Value by Countries (2015-2020)
7.2 Europe Transdermal Drug Patches Consumption by Type
7.3 Europe Transdermal Drug Patches Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Patches by Countries
8.1.1 Middle East & Africa Transdermal Drug Patches Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Transdermal Drug Patches Value by Countries (2015-2020)
8.2 Middle East & Africa Transdermal Drug Patches Consumption by Type
8.3 Middle East & Africa Transdermal Drug Patches Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transdermal Drug Patches Distributors
10.3 Transdermal Drug Patches Customer

11 Global Transdermal Drug Patches Market Forecast
11.1 Global Transdermal Drug Patches Consumption Forecast (2021-2025)
11.2 Global Transdermal Drug Patches Forecast by Regions
11.2.1 Global Transdermal Drug Patches Forecast by Regions (2021-2025)
11.2.2 Global Transdermal Drug Patches Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transdermal Drug Patches Forecast by Type
11.8 Global Transdermal Drug Patches Forecast by Application

12 Key Players Analysis
12.1 Noven
12.1.1 Company Information
12.1.2 Transdermal Drug Patches Product Offered
12.1.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Noven Latest Developments
12.2 DURECT Corporation
12.2.1 Company Information
12.2.2 Transdermal Drug Patches Product Offered
12.2.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 DURECT Corporation Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Transdermal Drug Patches Product Offered
12.3.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Transdermal Drug Patches Product Offered
12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Agile Therapeutics
12.5.1 Company Information
12.5.2 Transdermal Drug Patches Product Offered
12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Agile Therapeutics Latest Developments
12.6 Novartis
12.6.1 Company Information
12.6.2 Transdermal Drug Patches Product Offered
12.6.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novartis Latest Developments
12.7 Hercon Pharmaceuticals
12.7.1 Company Information
12.7.2 Transdermal Drug Patches Product Offered
12.7.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Hercon Pharmaceuticals Latest Developments
12.8 Teikoku Pharma USA
12.8.1 Company Information
12.8.2 Transdermal Drug Patches Product Offered
12.8.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Teikoku Pharma USA Latest Developments
12.9 Pocono
12.9.1 Company Information
12.9.2 Transdermal Drug Patches Product Offered
12.9.3 Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Pocono Latest Developments
12.10 Immune Pharmaceuticals
12.10.1 Company Information
12.10.2 Transdermal Drug Patches Product Offered
12.10.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Immune Pharmaceuticals Latest Developments
12.11 Xel Pharmaceuticals
12.11.1 Company Information
12.11.2 Transdermal Drug Patches Product Offered
12.11.3 Xel Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Xel Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Transdermal Drug Patches Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Fentanyl Transdermal Patch
Table 5. Major Players of Nicotine Transdermal Patch
Table 6. Major Players of Buprenorphine Transdermal Patch
Table 7. Major Players of Clonidine Transdermal Patch
Table 8. Major Players of Oxybutynin Transdermal Patch
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
Table 12. Global Transdermal Drug Patches Revenue by Type (2015-2020) ($ million)
Table 13. Global Transdermal Drug Patches Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Transdermal Drug Patches Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Transdermal Drug Patches Consumption Market Share by Application (2015-2020)
Table 17. Global Transdermal Drug Patches Value by Application (2015-2020)
Table 18. Global Transdermal Drug Patches Value Market Share by Application (2015-2020)
Table 19. Global Transdermal Drug Patches Sale Price by Application (2015-2020)
Table 20. Global Transdermal Drug Patches Sales by Company (2017-2019) (K Units)
Table 21. Global Transdermal Drug Patches Sales Market Share by Company (2017-2019)
Table 22. Global Transdermal Drug Patches Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Transdermal Drug Patches Revenue Market Share by Company (2017-2019)
Table 24. Global Transdermal Drug Patches Sale Price by Company (2017-2019)
Table 25. Global Transdermal Drug Patches Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Transdermal Drug Patches Products Offered
Table 27. Transdermal Drug Patches Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Transdermal Drug Patches Consumption by Regions 2015-2020 (K Units)
Table 29. Global Transdermal Drug Patches Consumption Market Share by Regions 2015-2020
Table 30. Global Transdermal Drug Patches Value by Regions 2015-2020 ($ Millions)
Table 31. Global Transdermal Drug Patches Value Market Share by Regions 2015-2020
Table 32. Americas Transdermal Drug Patches Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Transdermal Drug Patches Consumption Market Share by Countries (2015-2020)
Table 34. Americas Transdermal Drug Patches Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Transdermal Drug Patches Value Market Share by Countries (2015-2020)
Table 36. Americas Transdermal Drug Patches Consumption by Type (2015-2020) (K Units)
Table 37. Americas Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
Table 38. Americas Transdermal Drug Patches Consumption by Application (2015-2020) (K Units)
Table 39. Americas Transdermal Drug Patches Consumption Market Share by Application (2015-2020)
Table 40. APAC Transdermal Drug Patches Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Transdermal Drug Patches Consumption Market Share by Countries (2015-2020)
Table 42. APAC Transdermal Drug Patches Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Transdermal Drug Patches Value Market Share by Regions (2015-2020)
Table 44. APAC Transdermal Drug Patches Consumption by Type (2015-2020) (K Units)
Table 45. APAC Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
Table 46. APAC Transdermal Drug Patches Consumption by Application (2015-2020) (K Units)
Table 47. APAC Transdermal Drug Patches Consumption Market Share by Application (2015-2020)
Table 48. Europe Transdermal Drug Patches Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Transdermal Drug Patches Consumption Market Share by Countries (2015-2020)
Table 50. Europe Transdermal Drug Patches Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Transdermal Drug Patches Value Market Share by Countries (2015-2020)
Table 52. Europe Transdermal Drug Patches Consumption by Type (2015-2020) (K Units)
Table 53. Europe Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
Table 54. Europe Transdermal Drug Patches Consumption by Application (2015-2020) (K Units)
Table 55. Europe Transdermal Drug Patches Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Transdermal Drug Patches Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Transdermal Drug Patches Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Transdermal Drug Patches Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Transdermal Drug Patches Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Transdermal Drug Patches Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Transdermal Drug Patches Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Transdermal Drug Patches Consumption Market Share by Application (2015-2020)
Table 64. Transdermal Drug Patches Distributors List
Table 65. Transdermal Drug Patches Customer List
Table 66. Global Transdermal Drug Patches Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Transdermal Drug Patches Consumption Market Forecast by Regions
Table 68. Global Transdermal Drug Patches Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Transdermal Drug Patches Value Market Share Forecast by Regions
Table 70. Global Transdermal Drug Patches Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Transdermal Drug Patches Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Transdermal Drug Patches Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Transdermal Drug Patches Value Market Share Forecast by Type (2021-2025)
Table 74. Global Transdermal Drug Patches Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Transdermal Drug Patches Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Transdermal Drug Patches Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Transdermal Drug Patches Value Market Share Forecast by Application (2021-2025)
Table 78. Noven Product Offered
Table 79. Noven Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 80. Noven Main Business
Table 81. Noven Latest Developments
Table 82. Noven Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 83. DURECT Corporation Product Offered
Table 84. DURECT Corporation Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 85. DURECT Corporation Main Business
Table 86. DURECT Corporation Latest Developments
Table 87. DURECT Corporation Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 88. Mylan Product Offered
Table 89. Mylan Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 90. Mylan Main Business
Table 91. Mylan Latest Developments
Table 92. Mylan Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Product Offered
Table 94. Johnson & Johnson Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 98. Agile Therapeutics Product Offered
Table 99. Agile Therapeutics Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 100. Agile Therapeutics Main Business
Table 101. Agile Therapeutics Latest Developments
Table 102. Agile Therapeutics Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis Product Offered
Table 104. Novartis Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. Novartis Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 108. Hercon Pharmaceuticals Product Offered
Table 109. Hercon Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 110. Hercon Pharmaceuticals Main Business
Table 111. Hercon Pharmaceuticals Latest Developments
Table 112. Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 113. Teikoku Pharma USA Product Offered
Table 114. Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 115. Teikoku Pharma USA Main Business
Table 116. Teikoku Pharma USA Latest Developments
Table 117. Teikoku Pharma USA Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 118. Pocono Product Offered
Table 119. Pocono Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 120. Pocono Main Business
Table 121. Pocono Latest Developments
Table 122. Pocono Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 123. Immune Pharmaceuticals Product Offered
Table 124. Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 125. Immune Pharmaceuticals Main Business
Table 126. Immune Pharmaceuticals Latest Developments
Table 127. Immune Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 128. Xel Pharmaceuticals Product Offered
Table 129. Xel Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 130. Xel Pharmaceuticals Main Business
Table 131. Xel Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Xel Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Transdermal Drug Patches
Figure 2. Transdermal Drug Patches Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Transdermal Drug Patches Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Transdermal Drug Patches Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Fentanyl Transdermal Patch
Figure 7. Product Picture of Nicotine Transdermal Patch
Figure 8. Product Picture of Buprenorphine Transdermal Patch
Figure 9. Product Picture of Clonidine Transdermal Patch
Figure 10. Product Picture of Oxybutynin Transdermal Patch
Figure 11. Product Picture of Others
Figure 12. Global Transdermal Drug Patches Consumption Market Share by Type (2015-2020)
Figure 13. Global Transdermal Drug Patches Value Market Share by Type (2015-2020)
Figure 14. Transdermal Drug Patches Consumed in Used for Hypertension
Figure 15. Global Transdermal Drug Patches Market: Used for Hypertension (2015-2020) (K Units)
Figure 16. Global Transdermal Drug Patches Market: Used for Hypertension (2015-2020) ($ Millions)
Figure 17. Transdermal Drug Patches Consumed in Used for Contraception
Figure 18. Global Transdermal Drug Patches Market: Used for Contraception (2015-2020) (K Units)
Figure 19. Global Transdermal Drug Patches Market: Used for Contraception (2015-2020) ($ Millions)
Figure 20. Transdermal Drug Patches Consumed in Used for Analgesia
Figure 21. Global Transdermal Drug Patches Market: Used for Analgesia (2015-2020) (K Units)
Figure 22. Global Transdermal Drug Patches Market: Used for Analgesia (2015-2020) ($ Millions)
Figure 23. Transdermal Drug Patches Consumed in Used for Smoking Cessation
Figure 24. Global Transdermal Drug Patches Market: Used for Smoking Cessation (2015-2020) (K Units)
Figure 25. Global Transdermal Drug Patches Market: Used for Smoking Cessation (2015-2020) ($ Millions)
Figure 26. Transdermal Drug Patches Consumed in Used for Angina
Figure 27. Global Transdermal Drug Patches Market: Used for Angina (2015-2020) (K Units)
Figure 28. Global Transdermal Drug Patches Market: Used for Angina (2015-2020) ($ Millions)
Figure 29. Transdermal Drug Patches Consumed in Used for Hormone Replacement
Figure 30. Global Transdermal Drug Patches Consumption Market Share by Application (2015-2020)
Figure 31. Global Transdermal Drug Patches Value Market Share by Application (2015-2020)
Figure 32. Global Transdermal Drug Patches Sales Market Share by Company in 2017
Figure 33. Global Transdermal Drug Patches Sales Market Share by Company in 2019
Figure 34. Global Transdermal Drug Patches Revenue Market Share by Company in 2017
Figure 35. Global Transdermal Drug Patches Revenue Market Share by Company in 2019
Figure 36. Global Transdermal Drug Patches Sale Price by Company in 2019
Figure 37. Global Transdermal Drug Patches Consumption Market Share by Regions 2015-2020
Figure 38. Global Transdermal Drug Patches Value Market Share by Regions 2015-2020
Figure 39. Americas Transdermal Drug Patches Consumption 2015-2020 (K Units)
Figure 40. Americas Transdermal Drug Patches Value 2015-2020 ($ Millions)
Figure 41. APAC Transdermal Drug Patches Consumption 2015-2020 (K Units)
Figure 42. APAC Transdermal Drug Patches Value 2015-2020 ($ Millions)
Figure 43. Europe Transdermal Drug Patches Consumption 2015-2020 (K Units)
Figure 44. Europe Transdermal Drug Patches Value 2015-2020 ($ Millions)
Figure 45. Middle East & Africa Transdermal Drug Patches Consumption 2015-2020 (K Units)
Figure 46. Middle East & Africa Transdermal Drug Patches Value 2015-2020 ($ Millions)
Figure 47. Americas Transdermal Drug Patches Consumption Market Share by Countries in 2019
Figure 48. Americas Transdermal Drug Patches Value Market Share by Countries in 2019
Figure 49. Americas Transdermal Drug Patches Consumption Market Share by Type in 2019
Figure 50. Americas Transdermal Drug Patches Consumption Market Share by Application in 2019
Figure 51. United States Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 52. United States Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 53. Canada Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 54. Canada Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 55. Mexico Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 56. Mexico Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 57. APAC Transdermal Drug Patches Consumption Market Share by Countries in 2019
Figure 58. APAC Transdermal Drug Patches Value Market Share by Regions in 2019
Figure 59. APAC Transdermal Drug Patches Consumption Market Share by Type in 2019
Figure 60. APAC Transdermal Drug Patches Consumption Market Share by Application in 2019
Figure 61. China Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 62. China Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 63. Japan Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 64. Japan Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 65. Korea Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 66. Korea Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 67. Southeast Asia Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 68. Southeast Asia Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 69. India Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 70. India Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 71. Australia Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 72. Australia Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 73. Europe Transdermal Drug Patches Consumption Market Share by Countries in 2019
Figure 74. Europe Transdermal Drug Patches Value Market Share by Countries in 2019
Figure 75. Europe Transdermal Drug Patches Consumption Market Share by Type in 2019
Figure 76. Europe Transdermal Drug Patches Consumption Market Share by Application in 2019
Figure 77. Germany Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 78. Germany Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 79. France Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 80. France Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 81. UK Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 82. UK Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 83. Italy Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 84. Italy Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 85. Russia Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 86. Russia Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 87. Middle East & Africa Transdermal Drug Patches Consumption Market Share by Countries in 2019
Figure 88. Middle East & Africa Transdermal Drug Patches Value Market Share by Countries in 2019
Figure 89. Middle East & Africa Transdermal Drug Patches Consumption Market Share by Type in 2019
Figure 90. Middle East & Africa Transdermal Drug Patches Consumption Market Share by Application in 2019
Figure 91. Egypt Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 92. Egypt Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 93. South Africa Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 94. South Africa Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 95. Israel Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 96. Israel Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 97. Turkey Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 98. Turkey Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 99. GCC Countries Transdermal Drug Patches Consumption Growth 2015-2020 (K Units)
Figure 100. GCC Countries Transdermal Drug Patches Value Growth 2015-2020 ($ Millions)
Figure 101. Global Transdermal Drug Patches Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 102. Global Transdermal Drug Patches Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 103. Americas Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 104. Americas Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 105. APAC Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 106. APAC Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 107. Europe Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 108. Europe Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 109. Middle East & Africa Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 110. Middle East & Africa Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 111. United States Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 112. United States Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 113. Canada Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 114. Canada Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 115. Mexico Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 116. Mexico Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 117. Brazil Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 118. Brazil Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 119. China Transdermal Drug Patches Consumption 2021-2025 (K Units)
Figure 120. China Transdermal Drug Patches Value 2021-2025 ($ Millions)
Figure 121. Japan Transde
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs